People · Operator
Named in public records as an officer, director or promoter · active 2010–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Galleon Pharmaceuticals Inc | — | Biotechnology | Series A | $11.5M | $54.2M | 2010 |
Geoff C. Duyk at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Geoff C. Duyk on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Thomas J. Dietz | 1 | 2 |
| Ralph C. Christoffersen | 1 | 2 |
| James C. Mannion | 1 | 1 |
| Christopher C. Mirabelli | 1 | 1 |
| Chris C. Mirabelli | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.